Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angioplasty, Balloon, Coronary | 47 | 2012 | 1880 | 1.620 |
Why?
|
Stents | 44 | 2019 | 3303 | 1.080 |
Why?
|
Radial Artery | 4 | 2021 | 196 | 0.930 |
Why?
|
Coronary Restenosis | 15 | 2011 | 426 | 0.920 |
Why?
|
Catheterization, Peripheral | 3 | 2021 | 342 | 0.730 |
Why?
|
Pericarditis | 1 | 2021 | 135 | 0.700 |
Why?
|
Coronary Stenosis | 10 | 2019 | 820 | 0.680 |
Why?
|
Heart Injuries | 1 | 2021 | 208 | 0.680 |
Why?
|
Hospital Mortality | 13 | 2014 | 5418 | 0.610 |
Why?
|
Wrist | 1 | 2017 | 219 | 0.530 |
Why?
|
Coronary Angiography | 40 | 2021 | 4563 | 0.530 |
Why?
|
Coronary Disease | 29 | 2011 | 5991 | 0.510 |
Why?
|
Registries | 24 | 2021 | 8458 | 0.480 |
Why?
|
Myocarditis | 1 | 2021 | 766 | 0.460 |
Why?
|
Coronary Thrombosis | 10 | 2012 | 486 | 0.430 |
Why?
|
Angiography | 1 | 2017 | 1605 | 0.410 |
Why?
|
Myocardium | 6 | 2021 | 4700 | 0.380 |
Why?
|
Atherectomy, Coronary | 9 | 2006 | 146 | 0.350 |
Why?
|
Myocardial Infarction | 23 | 2019 | 11890 | 0.330 |
Why?
|
Vaccination | 1 | 2021 | 3359 | 0.330 |
Why?
|
Risk Adjustment | 3 | 2010 | 601 | 0.310 |
Why?
|
Electrocardiography | 11 | 2019 | 6415 | 0.310 |
Why?
|
Coronary Circulation | 1 | 2012 | 1577 | 0.270 |
Why?
|
Myocardial Ischemia | 7 | 2019 | 2164 | 0.230 |
Why?
|
Endovascular Procedures | 1 | 2017 | 2134 | 0.230 |
Why?
|
Aged | 85 | 2022 | 169143 | 0.220 |
Why?
|
Troponin I | 2 | 2009 | 638 | 0.220 |
Why?
|
Carotid Artery Diseases | 3 | 2019 | 881 | 0.210 |
Why?
|
Acute Coronary Syndrome | 2 | 2013 | 2365 | 0.210 |
Why?
|
Patient Identification Systems | 1 | 2001 | 75 | 0.190 |
Why?
|
Blood Chemical Analysis | 1 | 2003 | 437 | 0.190 |
Why?
|
Drug-Eluting Stents | 4 | 2014 | 757 | 0.190 |
Why?
|
Middle Aged | 86 | 2021 | 220359 | 0.190 |
Why?
|
Coronary Artery Disease | 8 | 2018 | 6659 | 0.180 |
Why?
|
Punctures | 3 | 2018 | 368 | 0.180 |
Why?
|
Treatment Outcome | 56 | 2022 | 64981 | 0.180 |
Why?
|
Thrombectomy | 5 | 2003 | 708 | 0.180 |
Why?
|
Graft Occlusion, Vascular | 6 | 2003 | 560 | 0.170 |
Why?
|
Cardiology | 5 | 2019 | 1723 | 0.170 |
Why?
|
Follow-Up Studies | 34 | 2021 | 39262 | 0.170 |
Why?
|
Male | 97 | 2022 | 359718 | 0.170 |
Why?
|
Sirolimus | 4 | 2008 | 1547 | 0.170 |
Why?
|
Creatine Kinase, MB Form | 4 | 2016 | 211 | 0.170 |
Why?
|
Models, Cardiovascular | 2 | 2011 | 977 | 0.160 |
Why?
|
Logistic Models | 15 | 2014 | 13312 | 0.160 |
Why?
|
Risk Assessment | 16 | 2016 | 24102 | 0.160 |
Why?
|
Endarterectomy, Carotid | 4 | 2019 | 559 | 0.160 |
Why?
|
Female | 95 | 2022 | 391246 | 0.160 |
Why?
|
Survival Analysis | 16 | 2013 | 10185 | 0.150 |
Why?
|
Massachusetts | 10 | 2016 | 8803 | 0.150 |
Why?
|
Incidence | 16 | 2021 | 21391 | 0.150 |
Why?
|
Decision Support Techniques | 4 | 2015 | 2001 | 0.150 |
Why?
|
Troponin | 1 | 2021 | 516 | 0.150 |
Why?
|
Time Factors | 27 | 2021 | 40139 | 0.150 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2008 | 638 | 0.150 |
Why?
|
Myocardial Reperfusion | 2 | 2008 | 347 | 0.140 |
Why?
|
Snow | 1 | 2017 | 15 | 0.140 |
Why?
|
Peripheral Arterial Disease | 2 | 2019 | 1305 | 0.140 |
Why?
|
Blood Vessel Prosthesis Implantation | 9 | 2007 | 1425 | 0.140 |
Why?
|
Coronary Artery Bypass | 7 | 2006 | 2272 | 0.140 |
Why?
|
Neuregulin-1 | 2 | 2009 | 135 | 0.140 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2018 | 273 | 0.140 |
Why?
|
Feasibility Studies | 7 | 2018 | 5201 | 0.140 |
Why?
|
Humans | 123 | 2022 | 760613 | 0.140 |
Why?
|
Sex Factors | 5 | 2021 | 10546 | 0.130 |
Why?
|
Discriminant Analysis | 2 | 2013 | 223 | 0.130 |
Why?
|
Postoperative Complications | 12 | 2016 | 15679 | 0.130 |
Why?
|
Risk Factors | 27 | 2018 | 74333 | 0.130 |
Why?
|
Quality Improvement | 5 | 2022 | 3835 | 0.130 |
Why?
|
Referral and Consultation | 3 | 2018 | 3598 | 0.130 |
Why?
|
Quality Indicators, Health Care | 4 | 2014 | 1822 | 0.130 |
Why?
|
Angioplasty, Balloon | 4 | 2011 | 597 | 0.120 |
Why?
|
Vascular System Injuries | 1 | 2018 | 247 | 0.120 |
Why?
|
Vasoconstriction | 1 | 2017 | 593 | 0.120 |
Why?
|
Nonlinear Dynamics | 1 | 1997 | 494 | 0.120 |
Why?
|
Myocardial Revascularization | 5 | 2008 | 841 | 0.120 |
Why?
|
Angina Pectoris | 1 | 2018 | 969 | 0.120 |
Why?
|
Heart Failure | 7 | 2004 | 11848 | 0.120 |
Why?
|
Exercise Tolerance | 1 | 2019 | 830 | 0.110 |
Why?
|
Specialization | 1 | 2019 | 778 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2019 | 1180 | 0.110 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2019 | 571 | 0.110 |
Why?
|
Saphenous Vein | 4 | 2004 | 537 | 0.110 |
Why?
|
Patient Selection | 6 | 2015 | 4279 | 0.110 |
Why?
|
Disclosure | 1 | 2019 | 738 | 0.110 |
Why?
|
Workload | 1 | 2019 | 847 | 0.110 |
Why?
|
Hospitals | 4 | 2022 | 3928 | 0.110 |
Why?
|
Treatment Failure | 2 | 2017 | 2647 | 0.100 |
Why?
|
Antacids | 1 | 2013 | 94 | 0.100 |
Why?
|
Multivariate Analysis | 8 | 2014 | 12159 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 413 | 0.100 |
Why?
|
Platelet Aggregation Inhibitors | 6 | 2022 | 3200 | 0.100 |
Why?
|
Vascular Malformations | 1 | 2017 | 464 | 0.100 |
Why?
|
United States | 27 | 2019 | 72448 | 0.100 |
Why?
|
Heart Atria | 1 | 2018 | 1346 | 0.100 |
Why?
|
Databases, Factual | 2 | 2011 | 8022 | 0.100 |
Why?
|
Atrial Fibrillation | 4 | 2022 | 5209 | 0.100 |
Why?
|
Exercise Test | 1 | 2019 | 2128 | 0.100 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2000 | 578 | 0.100 |
Why?
|
Mortality | 2 | 2002 | 2916 | 0.090 |
Why?
|
Sweating, Gustatory | 1 | 1990 | 7 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2018 | 2659 | 0.090 |
Why?
|
Hospitalization | 6 | 2019 | 10789 | 0.090 |
Why?
|
Odds Ratio | 7 | 2013 | 9716 | 0.090 |
Why?
|
Embolism | 3 | 2004 | 408 | 0.090 |
Why?
|
Creatine Kinase | 4 | 2009 | 691 | 0.090 |
Why?
|
Ganglia, Sympathetic | 1 | 1990 | 65 | 0.090 |
Why?
|
Urokinase-Type Plasminogen Activator | 2 | 2002 | 326 | 0.090 |
Why?
|
Aged, 80 and over | 16 | 2018 | 58980 | 0.090 |
Why?
|
Vascular Surgical Procedures | 1 | 2019 | 1469 | 0.090 |
Why?
|
Heart Rate | 2 | 2003 | 4180 | 0.090 |
Why?
|
Societies, Medical | 3 | 2011 | 3905 | 0.090 |
Why?
|
Quality Assurance, Health Care | 3 | 2011 | 2176 | 0.090 |
Why?
|
Survival Rate | 10 | 2019 | 12810 | 0.090 |
Why?
|
Equipment Design | 8 | 2014 | 3520 | 0.090 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2014 | 450 | 0.090 |
Why?
|
Hemorrhage | 3 | 2017 | 3599 | 0.090 |
Why?
|
Ticlopidine | 3 | 2008 | 895 | 0.090 |
Why?
|
Quality of Life | 6 | 2021 | 13308 | 0.080 |
Why?
|
Troponin T | 2 | 2016 | 774 | 0.080 |
Why?
|
Pulmonary Artery | 1 | 2018 | 1921 | 0.080 |
Why?
|
Health Status | 2 | 2021 | 4082 | 0.080 |
Why?
|
Equipment Safety | 2 | 2014 | 253 | 0.080 |
Why?
|
Shock, Cardiogenic | 2 | 2013 | 734 | 0.080 |
Why?
|
Predictive Value of Tests | 7 | 2015 | 15286 | 0.080 |
Why?
|
American Heart Association | 3 | 2008 | 1081 | 0.080 |
Why?
|
Bundle-Branch Block | 1 | 2010 | 281 | 0.080 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2008 | 60 | 0.080 |
Why?
|
Hemorheology | 3 | 2003 | 144 | 0.080 |
Why?
|
Fibrinolytic Agents | 3 | 2022 | 2167 | 0.070 |
Why?
|
Hypertension | 4 | 2008 | 8595 | 0.070 |
Why?
|
Cardiovascular Diseases | 4 | 2019 | 15760 | 0.070 |
Why?
|
Angioplasty | 1 | 2010 | 360 | 0.070 |
Why?
|
Cohort Studies | 10 | 2021 | 41337 | 0.070 |
Why?
|
Vectorcardiography | 2 | 2010 | 48 | 0.070 |
Why?
|
Multicenter Studies as Topic | 4 | 2006 | 1722 | 0.070 |
Why?
|
Health Policy | 1 | 2019 | 2677 | 0.070 |
Why?
|
Age Factors | 8 | 2011 | 18413 | 0.060 |
Why?
|
Boston | 8 | 2018 | 9278 | 0.060 |
Why?
|
Retrospective Studies | 19 | 2021 | 80345 | 0.060 |
Why?
|
Adult | 18 | 2021 | 220007 | 0.060 |
Why?
|
Young Adult | 4 | 2021 | 58748 | 0.060 |
Why?
|
Reoperation | 3 | 2005 | 4289 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2013 | 1131 | 0.060 |
Why?
|
Prospective Studies | 15 | 2019 | 54306 | 0.060 |
Why?
|
Leg | 2 | 2019 | 1091 | 0.060 |
Why?
|
Adolescent | 7 | 2021 | 87809 | 0.060 |
Why?
|
Cardiomegaly | 1 | 2008 | 593 | 0.060 |
Why?
|
Prognosis | 9 | 2021 | 29661 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 2005 | 192 | 0.060 |
Why?
|
Immunosuppressive Agents | 2 | 2007 | 4167 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2004 | 12531 | 0.060 |
Why?
|
Thrombosis | 3 | 2004 | 3051 | 0.060 |
Why?
|
Autoanalysis | 1 | 2003 | 71 | 0.060 |
Why?
|
Hospital Costs | 4 | 2003 | 976 | 0.050 |
Why?
|
Coronary Vessels | 3 | 2005 | 3112 | 0.050 |
Why?
|
Death | 1 | 2008 | 678 | 0.050 |
Why?
|
Technetium | 1 | 2003 | 321 | 0.050 |
Why?
|
Cardiovascular Agents | 1 | 2009 | 866 | 0.050 |
Why?
|
Sampling Studies | 1 | 2004 | 613 | 0.050 |
Why?
|
Strontium Radioisotopes | 1 | 2002 | 18 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2009 | 2128 | 0.050 |
Why?
|
Medical Audit | 2 | 2015 | 453 | 0.050 |
Why?
|
Beta Particles | 1 | 2002 | 47 | 0.050 |
Why?
|
Drug Delivery Systems | 4 | 2007 | 2221 | 0.050 |
Why?
|
Doxorubicin | 2 | 2009 | 2208 | 0.050 |
Why?
|
Isoenzymes | 2 | 2004 | 1690 | 0.050 |
Why?
|
Carotid Stenosis | 1 | 2010 | 872 | 0.050 |
Why?
|
Heart Diseases | 2 | 2009 | 2809 | 0.050 |
Why?
|
Radiography | 2 | 2011 | 6965 | 0.050 |
Why?
|
Autoantibodies | 1 | 1990 | 2119 | 0.050 |
Why?
|
Stroke | 4 | 2019 | 9952 | 0.050 |
Why?
|
Drug Utilization Review | 1 | 2003 | 251 | 0.050 |
Why?
|
Ulnar Artery | 1 | 2021 | 15 | 0.050 |
Why?
|
Yttrium Radioisotopes | 1 | 2002 | 107 | 0.050 |
Why?
|
Social Security | 1 | 2001 | 101 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 3 | 2005 | 2255 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5397 | 0.050 |
Why?
|
Ultrasonic Therapy | 1 | 2003 | 215 | 0.050 |
Why?
|
Catheters, Indwelling | 2 | 2002 | 428 | 0.050 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 1997 | 854 | 0.050 |
Why?
|
Smoking | 3 | 2004 | 9073 | 0.050 |
Why?
|
Tachycardia | 1 | 2003 | 603 | 0.050 |
Why?
|
False Positive Reactions | 1 | 2003 | 956 | 0.050 |
Why?
|
Algorithms | 5 | 2003 | 13982 | 0.040 |
Why?
|
Practice Guidelines as Topic | 3 | 2010 | 7475 | 0.040 |
Why?
|
Data Collection | 3 | 2019 | 3315 | 0.040 |
Why?
|
Pericardial Effusion | 1 | 2002 | 247 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2008 | 10343 | 0.040 |
Why?
|
Hemostasis, Surgical | 1 | 2000 | 129 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2019 | 4360 | 0.040 |
Why?
|
Kidney Failure, Chronic | 2 | 2003 | 2470 | 0.040 |
Why?
|
Hyperlipidemias | 1 | 2004 | 782 | 0.040 |
Why?
|
Echocardiography, Doppler | 1 | 2003 | 901 | 0.040 |
Why?
|
Paclitaxel | 1 | 2007 | 1737 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2006 | 1341 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2003 | 610 | 0.040 |
Why?
|
Brachytherapy | 2 | 2007 | 1238 | 0.040 |
Why?
|
Needles | 1 | 2002 | 451 | 0.040 |
Why?
|
Myocytes, Cardiac | 1 | 2008 | 1657 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2019 | 3465 | 0.040 |
Why?
|
Electrodes | 1 | 2001 | 614 | 0.040 |
Why?
|
Drug Therapy, Combination | 3 | 2022 | 6498 | 0.040 |
Why?
|
Recurrence | 9 | 2003 | 8483 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2003 | 784 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2003 | 1067 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 1796 | 0.040 |
Why?
|
Arm | 1 | 2021 | 583 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2007 | 5890 | 0.040 |
Why?
|
Health Resources | 1 | 2003 | 935 | 0.040 |
Why?
|
Comorbidity | 3 | 2013 | 10553 | 0.030 |
Why?
|
Cost-Benefit Analysis | 7 | 2011 | 5508 | 0.030 |
Why?
|
Entropy | 1 | 1997 | 210 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2002 | 1516 | 0.030 |
Why?
|
Models, Statistical | 3 | 2017 | 5075 | 0.030 |
Why?
|
Total Quality Management | 1 | 1997 | 265 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2282 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 1997 | 193 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2014 | 20080 | 0.030 |
Why?
|
Cerebrovascular Disorders | 2 | 2019 | 1501 | 0.030 |
Why?
|
Sensitivity and Specificity | 5 | 2002 | 14661 | 0.030 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1997 | 361 | 0.030 |
Why?
|
Clinical Competence | 1 | 2011 | 4783 | 0.030 |
Why?
|
Cardiology Service, Hospital | 1 | 1997 | 242 | 0.030 |
Why?
|
Suture Techniques | 1 | 2000 | 790 | 0.030 |
Why?
|
Anticoagulants | 2 | 2022 | 4897 | 0.030 |
Why?
|
Automation | 1 | 1997 | 580 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2012 | 2932 | 0.030 |
Why?
|
Stroke Volume | 2 | 2009 | 5523 | 0.030 |
Why?
|
Laser Therapy | 1 | 2002 | 1089 | 0.030 |
Why?
|
Embolic Protection Devices | 1 | 2014 | 43 | 0.030 |
Why?
|
Echocardiography | 3 | 2005 | 4981 | 0.030 |
Why?
|
Benchmarking | 2 | 2011 | 1044 | 0.030 |
Why?
|
Acute Disease | 5 | 2008 | 7268 | 0.030 |
Why?
|
Internet | 2 | 2008 | 3078 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2003 | 1801 | 0.030 |
Why?
|
Systole | 1 | 1996 | 947 | 0.030 |
Why?
|
Femoral Artery | 2 | 2013 | 831 | 0.030 |
Why?
|
Disease-Free Survival | 5 | 2002 | 6831 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2001 | 1266 | 0.030 |
Why?
|
Diastole | 1 | 1996 | 788 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2010 | 6544 | 0.030 |
Why?
|
Program Development | 2 | 2011 | 1297 | 0.030 |
Why?
|
Cold Temperature | 1 | 2017 | 780 | 0.030 |
Why?
|
Time and Motion Studies | 2 | 2007 | 143 | 0.030 |
Why?
|
Age Distribution | 2 | 2009 | 2893 | 0.030 |
Why?
|
Ultrasonography, Interventional | 2 | 1998 | 1501 | 0.030 |
Why?
|
Clinical Trials as Topic | 6 | 2005 | 8055 | 0.030 |
Why?
|
Combined Modality Therapy | 4 | 2007 | 8552 | 0.030 |
Why?
|
Blood Pressure | 1 | 2008 | 8525 | 0.020 |
Why?
|
Survivors | 1 | 2002 | 2375 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13505 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1925 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2014 | 14494 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 2 | 2002 | 221 | 0.020 |
Why?
|
Forecasting | 2 | 1998 | 2931 | 0.020 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1994 | 461 | 0.020 |
Why?
|
Cineangiography | 2 | 2002 | 113 | 0.020 |
Why?
|
Peptides | 1 | 2003 | 4354 | 0.020 |
Why?
|
Complement Fixation Tests | 1 | 1990 | 71 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2003 | 1941 | 0.020 |
Why?
|
Time | 2 | 2002 | 545 | 0.020 |
Why?
|
Dyspnea | 1 | 2018 | 1353 | 0.020 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 1997 | 1031 | 0.020 |
Why?
|
Risk | 3 | 2013 | 9632 | 0.020 |
Why?
|
Aspirin | 2 | 2001 | 3364 | 0.020 |
Why?
|
Reference Values | 1 | 1997 | 4925 | 0.020 |
Why?
|
Heart | 1 | 2003 | 4393 | 0.020 |
Why?
|
Warfarin | 1 | 1998 | 1518 | 0.020 |
Why?
|
Ventricular Function | 2 | 2005 | 408 | 0.020 |
Why?
|
Accidental Falls | 1 | 2017 | 1056 | 0.020 |
Why?
|
Canada | 2 | 2006 | 2126 | 0.020 |
Why?
|
Signal Transduction | 2 | 2009 | 23374 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2009 | 319 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2985 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2009 | 680 | 0.020 |
Why?
|
Prevalence | 4 | 2003 | 15686 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1926 | 0.020 |
Why?
|
Receptor, erbB-2 | 2 | 2009 | 2554 | 0.020 |
Why?
|
Atrial Natriuretic Factor | 1 | 2008 | 350 | 0.020 |
Why?
|
Advisory Committees | 1 | 2011 | 788 | 0.020 |
Why?
|
Drug Utilization | 1 | 2013 | 1195 | 0.020 |
Why?
|
Length of Stay | 3 | 2013 | 6476 | 0.020 |
Why?
|
Caspases | 1 | 2009 | 878 | 0.020 |
Why?
|
Syndrome | 2 | 2003 | 3280 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2008 | 1543 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2010 | 15840 | 0.020 |
Why?
|
Ventricular Function, Left | 2 | 2009 | 3880 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2009 | 1849 | 0.020 |
Why?
|
Cause of Death | 1 | 2016 | 3725 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 675 | 0.020 |
Why?
|
ROC Curve | 2 | 2004 | 3568 | 0.020 |
Why?
|
Platelet Count | 1 | 2008 | 777 | 0.020 |
Why?
|
Israel | 1 | 2007 | 722 | 0.020 |
Why?
|
Ubiquitination | 1 | 2009 | 1008 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2008 | 385 | 0.010 |
Why?
|
Aortic Valve Stenosis | 1 | 1997 | 2065 | 0.010 |
Why?
|
Eligibility Determination | 1 | 2008 | 419 | 0.010 |
Why?
|
Retreatment | 1 | 2006 | 600 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2477 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2002 | 36286 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2009 | 2671 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2005 | 186 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 613 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2294 | 0.010 |
Why?
|
Tachycardia, Sinus | 1 | 2003 | 42 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2003 | 7818 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2475 | 0.010 |
Why?
|
Heart Arrest | 1 | 2013 | 1506 | 0.010 |
Why?
|
Obesity | 1 | 2005 | 12919 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2009 | 1313 | 0.010 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2003 | 106 | 0.010 |
Why?
|
Belgium | 1 | 2002 | 118 | 0.010 |
Why?
|
Medicare | 2 | 2013 | 6785 | 0.010 |
Why?
|
Quebec | 1 | 2002 | 142 | 0.010 |
Why?
|
Xiphoid Bone | 1 | 2002 | 10 | 0.010 |
Why?
|
Health Care Costs | 3 | 2003 | 3258 | 0.010 |
Why?
|
Linear Models | 2 | 2004 | 5877 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2754 | 0.010 |
Why?
|
Australia | 1 | 2006 | 1290 | 0.010 |
Why?
|
Costs and Cost Analysis | 2 | 2000 | 1677 | 0.010 |
Why?
|
Glycoproteins | 1 | 2009 | 2208 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 1972 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2009 | 2435 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2007 | 1206 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1974 | 0.010 |
Why?
|
Filtration | 1 | 2002 | 229 | 0.010 |
Why?
|
Pilot Projects | 3 | 2002 | 8556 | 0.010 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2003 | 465 | 0.010 |
Why?
|
Regression Analysis | 2 | 2001 | 6359 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6218 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2005 | 866 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2448 | 0.010 |
Why?
|
Necrosis | 1 | 2005 | 1612 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4122 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2058 | 0.010 |
Why?
|
South Africa | 1 | 2006 | 1821 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5039 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2864 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2007 | 2129 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6538 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2008 | 2108 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4775 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2010 | 2283 | 0.010 |
Why?
|
Vascular Patency | 1 | 2002 | 901 | 0.010 |
Why?
|
Collagen | 1 | 2008 | 2636 | 0.010 |
Why?
|
Insulin | 2 | 2007 | 6596 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2873 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2008 | 6238 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2008 | 1716 | 0.010 |
Why?
|
Pacemaker, Artificial | 1 | 2005 | 815 | 0.010 |
Why?
|
Europe | 1 | 2006 | 3441 | 0.010 |
Why?
|
Depression | 1 | 2018 | 8045 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8311 | 0.010 |
Why?
|
Rats | 2 | 2009 | 23709 | 0.010 |
Why?
|
Heterozygote | 1 | 2005 | 2798 | 0.010 |
Why?
|
Endpoint Determination | 1 | 2001 | 597 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2362 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2004 | 1723 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3696 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2002 | 946 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2008 | 22052 | 0.010 |
Why?
|
Diabetic Angiopathies | 1 | 2003 | 822 | 0.010 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2003 | 615 | 0.010 |
Why?
|
Arteries | 1 | 2002 | 1126 | 0.010 |
Why?
|
Device Removal | 1 | 2002 | 635 | 0.010 |
Why?
|
Creatine | 1 | 1999 | 426 | 0.010 |
Why?
|
Demography | 1 | 2002 | 1650 | 0.010 |
Why?
|
Patient Admission | 1 | 2004 | 1385 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2003 | 12968 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 6180 | 0.010 |
Why?
|
Dogs | 1 | 2001 | 3841 | 0.010 |
Why?
|
Mice | 3 | 2009 | 81209 | 0.010 |
Why?
|
Drainage | 1 | 2002 | 1161 | 0.010 |
Why?
|
Mental Health | 2 | 2000 | 3213 | 0.010 |
Why?
|
Animals | 5 | 2009 | 167960 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1548 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7593 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2002 | 2897 | 0.010 |
Why?
|
Safety | 1 | 2000 | 1148 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2008 | 9530 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2000 | 968 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1998 | 1578 | 0.010 |
Why?
|
Renin | 1 | 1997 | 635 | 0.010 |
Why?
|
Causality | 1 | 2001 | 1242 | 0.010 |
Why?
|
Medicaid | 1 | 2008 | 2815 | 0.010 |
Why?
|
Hemodynamics | 1 | 2005 | 4173 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 1999 | 875 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2007 | 3149 | 0.010 |
Why?
|
Emergencies | 1 | 2001 | 1210 | 0.010 |
Why?
|
Norepinephrine | 1 | 1997 | 900 | 0.010 |
Why?
|
Family Practice | 1 | 1997 | 510 | 0.010 |
Why?
|
Lidocaine | 1 | 1997 | 538 | 0.010 |
Why?
|
Syncope | 1 | 1997 | 428 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 18955 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 1997 | 694 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 1999 | 2852 | 0.010 |
Why?
|
Chest Pain | 1 | 2000 | 1106 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 1997 | 1098 | 0.010 |
Why?
|
Educational Status | 1 | 2000 | 2514 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12762 | 0.010 |
Why?
|
Fees and Charges | 1 | 1993 | 191 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2640 | 0.010 |
Why?
|
Biphenyl Compounds | 1 | 1997 | 992 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2003 | 3562 | 0.010 |
Why?
|
Catheterization | 1 | 1997 | 1432 | 0.010 |
Why?
|
Pain Measurement | 1 | 2001 | 3527 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1997 | 1440 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1997 | 1259 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22020 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1994 | 1490 | 0.010 |
Why?
|
Tetrazoles | 1 | 1997 | 905 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2417 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2000 | 2696 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18137 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2005 | 14374 | 0.010 |
Why?
|
Aorta | 1 | 1997 | 2039 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2003 | 12427 | 0.000 |
Why?
|
Echocardiography, Transesophageal | 1 | 1994 | 1108 | 0.000 |
Why?
|
Antihypertensive Agents | 1 | 1997 | 2061 | 0.000 |
Why?
|
Life Expectancy | 1 | 1994 | 1247 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2003 | 9185 | 0.000 |
Why?
|
Health Services Research | 1 | 1993 | 1810 | 0.000 |
Why?
|
Child | 1 | 1997 | 79799 | 0.000 |
Why?
|